Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial

D. Hartgerink, A. Bruynzeel, D. Eekers, A. Swinnen, C. Hurkmans, R. Wiggenraad, A. Swaak-Kragten, E. Dieleman, P.P. Van der Toorn, L. van Veelen, J.J.C. Verhoeff, F. Lagerwaard, D. de Ruysscher, P. Lambin, J. Zindler*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages13
JournalAnnals of palliative medicine
DOIs
Publication statusE-pub ahead of print - 29 Oct 2021

Keywords

  • Brain metastases (BM)
  • stereotactic radiotherapy (SRT)
  • randomized controlled trial
  • palliative treatment
  • quality of life (QoL)
  • SURGICAL RESECTION
  • EORTC QLQ-BN20
  • RADIOSURGERY
  • CANCER

Cite this